Lysergic acid 3-pentyl amide (3-Pentyllysergamide LSP) is an analogue of LSD originally researched by David E. Nichols and colleagues at Purdue University. It has similar binding affinity to LSD itself as both a 5-HT1A and 5-HT2A agonist and produces similar behavioral and physiological responses in animals with only slightly lower potency than LSD.
This page contains content from the copyrighted Wikipedia article "Lysergic acid 3-pentyl amide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
